Spectrum of Surgico-Pathological Factors and Lymph Node Metastasis among Epithelial Ovarian Cancers: Experience of a Single Tertiary Care Institution from India

Introduction Epithelial ovarian cancer (EOC) is one of the leading causes of mortality among women worldwide. The present study aimed to estimate the frequency of various histopathological types, clinical and surgico-pathological factors, and spectrum of lymph node (LN) metastasis in early and advan...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:South Asian journal of cancer 2024-08
Hauptverfasser: Bahadur, Anupama, Verma, Pallavi, Rajaram, Shalini, Chaturvedi, Jaya, Kottayasamy Seenivasagam, Rajkumar, Mundhra, Rajlaxmi, Gaurav, Amrita, Rao, Shalinee, Panta, Shilpa, Chowdhuri, Sandipan
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title South Asian journal of cancer
container_volume
creator Bahadur, Anupama
Verma, Pallavi
Rajaram, Shalini
Chaturvedi, Jaya
Kottayasamy Seenivasagam, Rajkumar
Mundhra, Rajlaxmi
Gaurav, Amrita
Rao, Shalinee
Panta, Shilpa
Chowdhuri, Sandipan
description Introduction Epithelial ovarian cancer (EOC) is one of the leading causes of mortality among women worldwide. The present study aimed to estimate the frequency of various histopathological types, clinical and surgico-pathological factors, and spectrum of lymph node (LN) metastasis in early and advanced EOC. Material and Methods Women with EOCs who underwent cytoreductive surgery (CRS) between January 2019 and May 2022 were included. The distribution of Clinico-demographic parameters, histological type, stage, and LN metastasis were analyzed. Results A total of 101 women with EOCs underwent CRS, out of which 5 (4.95%) with coexistent endometrial cancer were excluded (N = 96). Fifty women (52%) underwent primary CRS and 46 (48%) women underwent interval CRS. The mean age of the women was 48.42 ± 11.6 years. Initial serum cancer antigen 125 (CA 125) level was elevated (>35 U/mL) in 88 (91.67%) women and normal in 8 (8.33%) women. Complete cytoreduction was achieved in 75 (78.12%) cases. High-grade serous carcinoma was the most common histology (66/96, 68.75%), followed by mucinous carcinoma (15/96, 15.63%), endometrioid carcinoma (6/96, 6.25%), low-grade serous carcinoma (4/96, 4.17%), and carcinosarcoma (2/96, 2.08%). The majority of women, 69 (71.88%), were in stages III and IV at presentation. Most serous carcinomas were diagnosed at stage III (71.22%) or IV (13.64%). In contrast, the majority of endometrioid, mucinous, and clear cell carcinomas were diagnosed at stages I and II. Seventy-five women (78.13%) with EOC underwent pelvic and/or para-aortic lymphadenectomy, out of which 23 (30.67%) were histologically positive. Three out of 23 patients (13%) with early-stage disease showed positive LNs. Conclusion Serous carcinoma ovary is the most common histological subtype, presenting mostly in the advanced stage. A significant number of affected women were younger at presentation and diagnosis was made a decade earlier than the western population. A systematic pelvic and para-aortic lymphadenectomy in apparently early-stage (pelvic confined) ovarian cancer could detect additional LNs in 13% of women, especially in high-grade tumors and serous histology, suggesting the role of systematic lymphadenectomy for accurate staging in apparently early-stage ovarian cancer.
doi_str_mv 10.1055/s-0044-1789581
format Article
fullrecord <record><control><sourceid>doaj_cross</sourceid><recordid>TN_cdi_crossref_primary_10_1055_s_0044_1789581</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><doaj_id>oai_doaj_org_article_2de58b5ba6d34c078f01db59e41149b0</doaj_id><sourcerecordid>oai_doaj_org_article_2de58b5ba6d34c078f01db59e41149b0</sourcerecordid><originalsourceid>FETCH-LOGICAL-c230t-6f6a444104cd5dfcbf3be95a169c1e847579e654ab08500f5aa9ab6862eadf3d3</originalsourceid><addsrcrecordid>eNo9UdtqHDEMHUILDUle--wfmFQe23PJW1k27cK2KWwCeRs0trzrMDMebG9p_qafWm-zBASSjqSjA6coPnO45aDUl1gCSFnypu1Uyy-Ky6pq2lIKqD-cayHg-VNxE-MLAHAQou34ZfF3t5BO4Tgxb9nuGPZO-_IXpoMffa5xZPeokw-R4WzY9nVaDuynN8R-UMKYw-XJ5Oc9Wy8uHWh0-eThNwaHM1vhrCnEO7b-s1BwlLvTG2Q7N-9HYo8UksPwmhcDsc0ck0vH5PzMbPBTBozD6-KjxTHSzTlfFU_368fV93L78G2z-rotdSUglbWtUUrJQWqjjNWDFQN1CnndaU6tbFTTUa0kDtAqAKsQOxzqtq4IjRVGXBWbN17j8aVfgpuysN6j6_8DPux7zGr1SH1lSLWDGrA2QmpoWgvcDKojybnsBshct29cOvgYA9l3Pg79ya4-9ie7-rNd4h9JoorJ</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Spectrum of Surgico-Pathological Factors and Lymph Node Metastasis among Epithelial Ovarian Cancers: Experience of a Single Tertiary Care Institution from India</title><source>DOAJ Directory of Open Access Journals</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>PubMed Central Open Access</source><source>Thieme Connect Journals Open Access</source><source>PubMed Central</source><creator>Bahadur, Anupama ; Verma, Pallavi ; Rajaram, Shalini ; Chaturvedi, Jaya ; Kottayasamy Seenivasagam, Rajkumar ; Mundhra, Rajlaxmi ; Gaurav, Amrita ; Rao, Shalinee ; Panta, Shilpa ; Chowdhuri, Sandipan</creator><creatorcontrib>Bahadur, Anupama ; Verma, Pallavi ; Rajaram, Shalini ; Chaturvedi, Jaya ; Kottayasamy Seenivasagam, Rajkumar ; Mundhra, Rajlaxmi ; Gaurav, Amrita ; Rao, Shalinee ; Panta, Shilpa ; Chowdhuri, Sandipan</creatorcontrib><description>Introduction Epithelial ovarian cancer (EOC) is one of the leading causes of mortality among women worldwide. The present study aimed to estimate the frequency of various histopathological types, clinical and surgico-pathological factors, and spectrum of lymph node (LN) metastasis in early and advanced EOC. Material and Methods Women with EOCs who underwent cytoreductive surgery (CRS) between January 2019 and May 2022 were included. The distribution of Clinico-demographic parameters, histological type, stage, and LN metastasis were analyzed. Results A total of 101 women with EOCs underwent CRS, out of which 5 (4.95%) with coexistent endometrial cancer were excluded (N = 96). Fifty women (52%) underwent primary CRS and 46 (48%) women underwent interval CRS. The mean age of the women was 48.42 ± 11.6 years. Initial serum cancer antigen 125 (CA 125) level was elevated (&gt;35 U/mL) in 88 (91.67%) women and normal in 8 (8.33%) women. Complete cytoreduction was achieved in 75 (78.12%) cases. High-grade serous carcinoma was the most common histology (66/96, 68.75%), followed by mucinous carcinoma (15/96, 15.63%), endometrioid carcinoma (6/96, 6.25%), low-grade serous carcinoma (4/96, 4.17%), and carcinosarcoma (2/96, 2.08%). The majority of women, 69 (71.88%), were in stages III and IV at presentation. Most serous carcinomas were diagnosed at stage III (71.22%) or IV (13.64%). In contrast, the majority of endometrioid, mucinous, and clear cell carcinomas were diagnosed at stages I and II. Seventy-five women (78.13%) with EOC underwent pelvic and/or para-aortic lymphadenectomy, out of which 23 (30.67%) were histologically positive. Three out of 23 patients (13%) with early-stage disease showed positive LNs. Conclusion Serous carcinoma ovary is the most common histological subtype, presenting mostly in the advanced stage. A significant number of affected women were younger at presentation and diagnosis was made a decade earlier than the western population. A systematic pelvic and para-aortic lymphadenectomy in apparently early-stage (pelvic confined) ovarian cancer could detect additional LNs in 13% of women, especially in high-grade tumors and serous histology, suggesting the role of systematic lymphadenectomy for accurate staging in apparently early-stage ovarian cancer.</description><identifier>ISSN: 2278-330X</identifier><identifier>EISSN: 2278-4306</identifier><identifier>DOI: 10.1055/s-0044-1789581</identifier><language>eng</language><publisher>Thieme Medical and Scientific Publishers Pvt. Ltd</publisher><subject>cytoreductive surgery ; epithelial ovarian cancer ; lymph node metastasis ; ovarian cancer ; surgico-pathologic factors</subject><ispartof>South Asian journal of cancer, 2024-08</ispartof><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c230t-6f6a444104cd5dfcbf3be95a169c1e847579e654ab08500f5aa9ab6862eadf3d3</cites><orcidid>0000-0002-8672-2463 ; 0000-0002-7888-4251</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>315,781,785,865,27929,27930</link.rule.ids></links><search><creatorcontrib>Bahadur, Anupama</creatorcontrib><creatorcontrib>Verma, Pallavi</creatorcontrib><creatorcontrib>Rajaram, Shalini</creatorcontrib><creatorcontrib>Chaturvedi, Jaya</creatorcontrib><creatorcontrib>Kottayasamy Seenivasagam, Rajkumar</creatorcontrib><creatorcontrib>Mundhra, Rajlaxmi</creatorcontrib><creatorcontrib>Gaurav, Amrita</creatorcontrib><creatorcontrib>Rao, Shalinee</creatorcontrib><creatorcontrib>Panta, Shilpa</creatorcontrib><creatorcontrib>Chowdhuri, Sandipan</creatorcontrib><title>Spectrum of Surgico-Pathological Factors and Lymph Node Metastasis among Epithelial Ovarian Cancers: Experience of a Single Tertiary Care Institution from India</title><title>South Asian journal of cancer</title><description>Introduction Epithelial ovarian cancer (EOC) is one of the leading causes of mortality among women worldwide. The present study aimed to estimate the frequency of various histopathological types, clinical and surgico-pathological factors, and spectrum of lymph node (LN) metastasis in early and advanced EOC. Material and Methods Women with EOCs who underwent cytoreductive surgery (CRS) between January 2019 and May 2022 were included. The distribution of Clinico-demographic parameters, histological type, stage, and LN metastasis were analyzed. Results A total of 101 women with EOCs underwent CRS, out of which 5 (4.95%) with coexistent endometrial cancer were excluded (N = 96). Fifty women (52%) underwent primary CRS and 46 (48%) women underwent interval CRS. The mean age of the women was 48.42 ± 11.6 years. Initial serum cancer antigen 125 (CA 125) level was elevated (&gt;35 U/mL) in 88 (91.67%) women and normal in 8 (8.33%) women. Complete cytoreduction was achieved in 75 (78.12%) cases. High-grade serous carcinoma was the most common histology (66/96, 68.75%), followed by mucinous carcinoma (15/96, 15.63%), endometrioid carcinoma (6/96, 6.25%), low-grade serous carcinoma (4/96, 4.17%), and carcinosarcoma (2/96, 2.08%). The majority of women, 69 (71.88%), were in stages III and IV at presentation. Most serous carcinomas were diagnosed at stage III (71.22%) or IV (13.64%). In contrast, the majority of endometrioid, mucinous, and clear cell carcinomas were diagnosed at stages I and II. Seventy-five women (78.13%) with EOC underwent pelvic and/or para-aortic lymphadenectomy, out of which 23 (30.67%) were histologically positive. Three out of 23 patients (13%) with early-stage disease showed positive LNs. Conclusion Serous carcinoma ovary is the most common histological subtype, presenting mostly in the advanced stage. A significant number of affected women were younger at presentation and diagnosis was made a decade earlier than the western population. A systematic pelvic and para-aortic lymphadenectomy in apparently early-stage (pelvic confined) ovarian cancer could detect additional LNs in 13% of women, especially in high-grade tumors and serous histology, suggesting the role of systematic lymphadenectomy for accurate staging in apparently early-stage ovarian cancer.</description><subject>cytoreductive surgery</subject><subject>epithelial ovarian cancer</subject><subject>lymph node metastasis</subject><subject>ovarian cancer</subject><subject>surgico-pathologic factors</subject><issn>2278-330X</issn><issn>2278-4306</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><sourceid>DOA</sourceid><recordid>eNo9UdtqHDEMHUILDUle--wfmFQe23PJW1k27cK2KWwCeRs0trzrMDMebG9p_qafWm-zBASSjqSjA6coPnO45aDUl1gCSFnypu1Uyy-Ky6pq2lIKqD-cayHg-VNxE-MLAHAQou34ZfF3t5BO4Tgxb9nuGPZO-_IXpoMffa5xZPeokw-R4WzY9nVaDuynN8R-UMKYw-XJ5Oc9Wy8uHWh0-eThNwaHM1vhrCnEO7b-s1BwlLvTG2Q7N-9HYo8UksPwmhcDsc0ck0vH5PzMbPBTBozD6-KjxTHSzTlfFU_368fV93L78G2z-rotdSUglbWtUUrJQWqjjNWDFQN1CnndaU6tbFTTUa0kDtAqAKsQOxzqtq4IjRVGXBWbN17j8aVfgpuysN6j6_8DPux7zGr1SH1lSLWDGrA2QmpoWgvcDKojybnsBshct29cOvgYA9l3Pg79ya4-9ie7-rNd4h9JoorJ</recordid><startdate>20240827</startdate><enddate>20240827</enddate><creator>Bahadur, Anupama</creator><creator>Verma, Pallavi</creator><creator>Rajaram, Shalini</creator><creator>Chaturvedi, Jaya</creator><creator>Kottayasamy Seenivasagam, Rajkumar</creator><creator>Mundhra, Rajlaxmi</creator><creator>Gaurav, Amrita</creator><creator>Rao, Shalinee</creator><creator>Panta, Shilpa</creator><creator>Chowdhuri, Sandipan</creator><general>Thieme Medical and Scientific Publishers Pvt. Ltd</general><scope>AAYXX</scope><scope>CITATION</scope><scope>DOA</scope><orcidid>https://orcid.org/0000-0002-8672-2463</orcidid><orcidid>https://orcid.org/0000-0002-7888-4251</orcidid></search><sort><creationdate>20240827</creationdate><title>Spectrum of Surgico-Pathological Factors and Lymph Node Metastasis among Epithelial Ovarian Cancers: Experience of a Single Tertiary Care Institution from India</title><author>Bahadur, Anupama ; Verma, Pallavi ; Rajaram, Shalini ; Chaturvedi, Jaya ; Kottayasamy Seenivasagam, Rajkumar ; Mundhra, Rajlaxmi ; Gaurav, Amrita ; Rao, Shalinee ; Panta, Shilpa ; Chowdhuri, Sandipan</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c230t-6f6a444104cd5dfcbf3be95a169c1e847579e654ab08500f5aa9ab6862eadf3d3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><topic>cytoreductive surgery</topic><topic>epithelial ovarian cancer</topic><topic>lymph node metastasis</topic><topic>ovarian cancer</topic><topic>surgico-pathologic factors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Bahadur, Anupama</creatorcontrib><creatorcontrib>Verma, Pallavi</creatorcontrib><creatorcontrib>Rajaram, Shalini</creatorcontrib><creatorcontrib>Chaturvedi, Jaya</creatorcontrib><creatorcontrib>Kottayasamy Seenivasagam, Rajkumar</creatorcontrib><creatorcontrib>Mundhra, Rajlaxmi</creatorcontrib><creatorcontrib>Gaurav, Amrita</creatorcontrib><creatorcontrib>Rao, Shalinee</creatorcontrib><creatorcontrib>Panta, Shilpa</creatorcontrib><creatorcontrib>Chowdhuri, Sandipan</creatorcontrib><collection>CrossRef</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>South Asian journal of cancer</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Bahadur, Anupama</au><au>Verma, Pallavi</au><au>Rajaram, Shalini</au><au>Chaturvedi, Jaya</au><au>Kottayasamy Seenivasagam, Rajkumar</au><au>Mundhra, Rajlaxmi</au><au>Gaurav, Amrita</au><au>Rao, Shalinee</au><au>Panta, Shilpa</au><au>Chowdhuri, Sandipan</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Spectrum of Surgico-Pathological Factors and Lymph Node Metastasis among Epithelial Ovarian Cancers: Experience of a Single Tertiary Care Institution from India</atitle><jtitle>South Asian journal of cancer</jtitle><date>2024-08-27</date><risdate>2024</risdate><issn>2278-330X</issn><eissn>2278-4306</eissn><abstract>Introduction Epithelial ovarian cancer (EOC) is one of the leading causes of mortality among women worldwide. The present study aimed to estimate the frequency of various histopathological types, clinical and surgico-pathological factors, and spectrum of lymph node (LN) metastasis in early and advanced EOC. Material and Methods Women with EOCs who underwent cytoreductive surgery (CRS) between January 2019 and May 2022 were included. The distribution of Clinico-demographic parameters, histological type, stage, and LN metastasis were analyzed. Results A total of 101 women with EOCs underwent CRS, out of which 5 (4.95%) with coexistent endometrial cancer were excluded (N = 96). Fifty women (52%) underwent primary CRS and 46 (48%) women underwent interval CRS. The mean age of the women was 48.42 ± 11.6 years. Initial serum cancer antigen 125 (CA 125) level was elevated (&gt;35 U/mL) in 88 (91.67%) women and normal in 8 (8.33%) women. Complete cytoreduction was achieved in 75 (78.12%) cases. High-grade serous carcinoma was the most common histology (66/96, 68.75%), followed by mucinous carcinoma (15/96, 15.63%), endometrioid carcinoma (6/96, 6.25%), low-grade serous carcinoma (4/96, 4.17%), and carcinosarcoma (2/96, 2.08%). The majority of women, 69 (71.88%), were in stages III and IV at presentation. Most serous carcinomas were diagnosed at stage III (71.22%) or IV (13.64%). In contrast, the majority of endometrioid, mucinous, and clear cell carcinomas were diagnosed at stages I and II. Seventy-five women (78.13%) with EOC underwent pelvic and/or para-aortic lymphadenectomy, out of which 23 (30.67%) were histologically positive. Three out of 23 patients (13%) with early-stage disease showed positive LNs. Conclusion Serous carcinoma ovary is the most common histological subtype, presenting mostly in the advanced stage. A significant number of affected women were younger at presentation and diagnosis was made a decade earlier than the western population. A systematic pelvic and para-aortic lymphadenectomy in apparently early-stage (pelvic confined) ovarian cancer could detect additional LNs in 13% of women, especially in high-grade tumors and serous histology, suggesting the role of systematic lymphadenectomy for accurate staging in apparently early-stage ovarian cancer.</abstract><pub>Thieme Medical and Scientific Publishers Pvt. Ltd</pub><doi>10.1055/s-0044-1789581</doi><orcidid>https://orcid.org/0000-0002-8672-2463</orcidid><orcidid>https://orcid.org/0000-0002-7888-4251</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 2278-330X
ispartof South Asian journal of cancer, 2024-08
issn 2278-330X
2278-4306
language eng
recordid cdi_crossref_primary_10_1055_s_0044_1789581
source DOAJ Directory of Open Access Journals; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; PubMed Central Open Access; Thieme Connect Journals Open Access; PubMed Central
subjects cytoreductive surgery
epithelial ovarian cancer
lymph node metastasis
ovarian cancer
surgico-pathologic factors
title Spectrum of Surgico-Pathological Factors and Lymph Node Metastasis among Epithelial Ovarian Cancers: Experience of a Single Tertiary Care Institution from India
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-14T12%3A05%3A38IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-doaj_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Spectrum%20of%20Surgico-Pathological%20Factors%20and%20Lymph%20Node%20Metastasis%20among%20Epithelial%20Ovarian%20Cancers:%20Experience%20of%20a%20Single%20Tertiary%20Care%20Institution%20from%20India&rft.jtitle=South%20Asian%20journal%20of%20cancer&rft.au=Bahadur,%20Anupama&rft.date=2024-08-27&rft.issn=2278-330X&rft.eissn=2278-4306&rft_id=info:doi/10.1055/s-0044-1789581&rft_dat=%3Cdoaj_cross%3Eoai_doaj_org_article_2de58b5ba6d34c078f01db59e41149b0%3C/doaj_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rft_doaj_id=oai_doaj_org_article_2de58b5ba6d34c078f01db59e41149b0&rfr_iscdi=true